Document Detail

Essential thrombocythaemia and its neurological complications.
MedLine Citation:
PMID:  20647525     Owner:  NLM     Status:  In-Process    
Essential thrombocythaemia is one of the chronic myeloproliferative neoplasms and is characterised by a sustained platelet count > or = 450 x 10(9)/l. The clinical course is often indolent but a significant number of patients have thrombotic and haemorrhagic complications. A patient with neurological complications is described, and the pathogenesis and clinical features of this disease are reviewed, including its neurological sequelae and management, along with an outline for the investigation of patients with thrombocytosis.
Thomas D Miller; Mira H Farquharson
Related Documents :
15230745 - Silent embolism in diagnostic cerebral angiography: detection with diffusion-weighted i...
16763975 - Extrapyramidal symptoms in wilson's disease are associated with olfactory dysfunction.
7354355 - Cricopharyngeal myotomy in motor neurone disease.
2631695 - Neurological impairment in violent schizophrenic inpatients.
20215825 - Importance of axial penile rigidity in objective evaluation of erection quality in pati...
1569675 - The urological manifestations of chronic granulomatous disease.
Publication Detail:
Type:  Case Reports; Journal Article; Review    
Journal Detail:
Title:  Practical neurology     Volume:  10     ISSN:  1474-7766     ISO Abbreviation:  Pract Neurol     Publication Date:  2010 Aug 
Date Detail:
Created Date:  2010-07-21     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101130961     Medline TA:  Pract Neurol     Country:  England    
Other Details:
Languages:  eng     Pagination:  195-201     Citation Subset:  IM    
Division of Clinical Neurosciences, University of Edinburgh, Western General Hospital, Edinburgh EH4 2XU, UK.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Accessory nerve palsies.
Next Document:  Do CSF biomarkers help clinicians predict the progression of mild cognitive impairment to dementia?